Wolverine Trading
SUPN icon

Wolverine Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Wolverine Trading’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,000
Closed -$218K – 6157
2025
Q2 		$218K Buy
+7,000
New +$224K ﹤0.01% 3820
2021
Q3 		– Sell
-6,700
Closed -$212K – 6929
2021
Q2 		$212K Sell
6,700
-17,000
-72% -$521K ﹤0.01% 4947
2021
Q1 		$620K Buy
+23,700
New +$663K ﹤0.01% 3412
2020
Q2 		– Sell
-12,700
Closed -$218K – 5212
2020
Q1 		$218K Sell
12,700
-15,000
-54% -$315K ﹤0.01% 3595
2019
Q4 		$647K Buy
27,700
+6,400
+30% +$155K ﹤0.01% 2844
2019
Q3 		$585K Buy
21,300
+6,500
+44% +$193K ﹤0.01% 2467
2019
Q2 		$490K Sell
14,800
-21,200
-59% -$726K ﹤0.01% 2743
2019
Q1 		$1.26M Buy
36,000
+8,100
+29% +$301K ﹤0.01% 1867
2018
Q4 		$903K Sell
27,900
-16,000
-36% -$688K ﹤0.01% 2062
2018
Q3 		$2.21M Buy
43,900
+18,900
+76% +$933K ﹤0.01% 1577
2018
Q2 		$1.15M Hold
25,000
– – ﹤0.01% 2121
2018
Q1 		$1.15M Buy
+25,000
New +$1.04M ﹤0.01% 2121
2017
Q3 		– Sell
-29,000
Closed -$1.24M – 5002
2017
Q2 		$1.24M Sell
29,000
-18,500
-39% -$658K 0.01% 1566
2017
Q1 		$1.48M Buy
47,500
+28,900
+155% +$774K 0.01% 1406
2016
Q4 		$470K Buy
18,600
+600
+3% +$13.4K ﹤0.01% 2707
2016
Q3 		$443K Buy
18,000
+7,700
+75% +$174K ﹤0.01% 2722
2016
Q2 		$204K Buy
+10,300
New +$183K ﹤0.01% 3260

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's SUPN Position: Q2 2021 in Review

Wolverine Trading sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 7,641 shares — an estimated $234K sold.

Wolverine Trading first reported a position in SUPN in Q2 2016 and held it in 8 quarters. The position peaked at $737K in Q4 2018. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • Wolverine Trading reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 7,641 Supernus Pharmaceuticals shares in Q2 2021, an estimated $234K.
  • Wolverine Trading first reported a position in Supernus Pharmaceuticals in Q2 2016 and held it in 8 quarters.
  • Wolverine Trading's Supernus Pharmaceuticals position peaked at $737K in Q4 2018.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.